Horizon Therapeutics Public Ltd Co

Grantham, Mayo, Van Otterloo & Co. LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

123,376

Value ($000)

14,273

Weight

0.1%

2022 Q4 - 2023 Q3 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	14,273	0.1%	123,376	9/30/2023
2023 Q2	8/14/2023	32,183	0.1%	312,911	6/30/2023
2023 Q1	5/12/2023	23,559	0.1%	215,859	3/31/2023
2022 Q4	2/13/2023	5,041	0.0%	44,296	12/31/2022